Duration of anti-tubercular therapy in uveitis associated with latent tuberculosis: A case-control study

British Journal of Ophthalmology

Volumn 96, Issue 3, 2012, Pages 332-336

  Ang, Marcus ^a,b   Hedayatfar, Alireza ^a   Wong, Wanling ^b,c   Chee, Soon Phaik ^a,c  

^a SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^b SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; ETHAMBUTOL; ISONIAZID; PREDNISOLONE; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; LATENT TUBERCULOSIS; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TUBERCULIN TEST; TUBERCULOSIS CONTROL; UVEITIS;

ADULT; ANTITUBERCULAR AGENTS; CASE-CONTROL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS; TUBERCULIN TEST; TUBERCULOSIS, OCULAR; UVEITIS;

EID: 84857114146     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2011-300209     Document Type: Article

References (35)

1. Anon. Global tuberculosis control: key findings from the December 2009 WHO report. Wkly Epidemiol Rec 2010;85:69-80.
2. Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis 1993;17:968-75. (Pubitemid 23358739)
3. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep 2000;49:1-51.
4. Rathinam SR, Namperumalsamy P. Global variation and pattern changes in epidemiology of uveitis. Indian J Ophthalmol 2007;55:173-83.
5. Ang M, Htoon HM, Chee SP. Diagnosis of tuberculous uveitis: clinical application of an interferon-gamma release assay. Ophthalmology 2009;116:1391-6.
6. Chee CB, KhinMar KW, Gan SH, et al. Latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis-specific antigens. Am J Respir Crit Care Med 2007;175:282-7.
7. Morimura Y, Okada AA, Kawahara S, et al. Tuberculin skin testing in uveitis patients and treatment of presumed intraocular tuberculosis in Japan. Ophthalmology 2002;109:851-7. (Pubitemid 34465215)
8. Gupta V, Gupta A, Rao NA. Intraocular tuberculosis-an update. Surv Ophthalmol 2007;52:561-87. (Pubitemid 350102547)
9. Rao NA, Saraswathy S, Smith RE. Tuberculous uveitis: distribution of Mycobacterium tuberculosis in the retinal pigment epithelium. Arch Ophthalmol 2006;124:1777-9. (Pubitemid 44913204)
10. Bansal R, Gupta A, Gupta V, et al. Role of anti-tubercular therapy in uveitis with latent/manifest tuberculosis. Am J Ophthalmol 2008;146:772-9.
11. Psilas K, Aspiotis M, Petroutsos G, et al. Antituberculosis therapy in the treatment of peripheral uveitis. Ann Ophthalmol 1991;23:254-8.
12. Gupta A, Gupta V. Tubercular posterior uveitis. Int Ophthalmol Clin 2005;45:71-88. (Pubitemid 40570754)
13. Gupta V, Gupta A, Sachdeva N, et al. Successful management of tubercular subretinal granulomas. Ocul Immunol Inflamm 2006;14:35-40. (Pubitemid 43336317)
14. Alvarez GG, Roth VR, Hodge W. Ocular tuberculosis: diagnostic and treatment challenges. Int J Infect Dis 2009;13:432-5.
15. Tabbara KF. Tuberculosis. Curr Opin Ophthalmol 2007;18:493-501. (Pubitemid 351339404)
16. Chee CB, Soh CH, Boudville IC, et al. Interpretation of the tuberculin skin test in Mycobacterium bovis BCG-vaccinated Singaporean schoolchildren. Am J Respir Crit Care Med 2001;164:958-61. (Pubitemid 32971640)
17. Cutter J, Wang YT. Tuberculosis - an under-appreciated disease. Ann Acad Med Singapore 2010;39:261-2.
18. Vasconcelos-Santos DV, Zierhut M, Rao NA. Strengths and weaknesses of diagnostic tools for tuberculous uveitis. Ocul Immunol Inflamm 2009;17:351-5.
19. Chee CB, Teleman MD, Boudville IC, et al. Treatment of latent TB infection for close contacts as a complementary TB control strategy in Singapore. Int J Tuberc Lung Dis 2004;8:226-31. (Pubitemid 38622931)
20. Cheung CM, Chee SP. Jarisch-Herxheimer reaction: paradoxical worsening of tuberculosis chorioretinitis following initiation of antituberculous therapy. Eye (Lond) 2009;23:1472-3.
21. Deschenes J, Murray PI, Rao NA, et al. International Uveitis Study Group (IUSG): clinical classification of uveitis. Ocul Immunol Inflamm 2008;16:1-2. (Pubitemid 351480322)
22. Garip A, Diedrichs-Möhring M, Thurau SR, et al. Uveitis in a patient treated with Bacille-Calmette-Guérin: possible antigenic mimicry of mycobacterial and retinal antigens. Ophthalmology 2009;116:2457-62. e1-2.
23. Guex-Crosier Y, Chamot L, Zografos L. Chorioretinitis induced by intravesical Bacillus Calmette-Guérin (BCG) instillations for urinary bladder carcinoma. Klin Monbl Augenheilkd 2003;220:193-5. (Pubitemid 36402477)
24. Spratt A, Key T, Vivian AJ. Chronic anterior uveitis following Bacille Calmette-Guérin vaccination: molecular mimicry in action? J Pediatr Ophthalmol Strabismus 2008;45:252-3.
25. Biswas J, Shome D. Choroidal tubercles in disseminated tuberculosis diagnosed by the polymerase chain reaction of aqueous humor. A case report and review of the literature. Ocul Immunol Inflamm 2002;10:293-8. (Pubitemid 36886372)
26. Waheeb S, Al-Saadi M, Quinn AG, et al. Tuberculous chorioretinitis. Can J Ophthalmol 2001;36:344-6. (Pubitemid 34193732)
27. Grosse V, Bange FC, Tischendorf J, et al. A mass in the eye. Lancet 2002;360:922. (Pubitemid 35283837)
28. Gupta A, Bansal R, Gupta V, et al. Ocular signs predictive of tubercular uveitis. Am J Ophthalmol 2010;149:562-70.
29. Cimino L, Herbort CP, Aldigeri R, et al. Tuberculous uveitis, a resurgent and underdiagnosed disease. Int Ophthalmol 2009;29:67-74.
30. Chang JH, Wakefield D. Uveitis: a global perspective. Ocul Immunol Inflamm 2002;10:263-79. (Pubitemid 36886369)
31. American Thoracic Society, CDC, Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Recomm Rep 2003;52:1-77.
32. Barton LL. Treatment of latent tuberculosis infection. N Engl J Med 2003;348:1292-3; author reply -3.
33. Darby CM, Nathan CF. Killing of non-replicating Mycobacterium tuberculosis by 8-hydroxyquinoline. J Antimicrob Chemother 2010;65:1424-7.
34. Gandhi NR, Nunn P, Dheda K, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 2010;375:1830-43.
35. Hamade IH, Tabbara KF. Complications of presumed ocular tuberculosis. Acta Ophthalmol 2010;88:905-9.